Erlotinib Hydrochloride CAS 183319-69-9 Purity >99.0% (HPLC)
Kaihanga rangatira me te kaiwhakarato o Erlotinib Hydrochloride Intermediates
Erlotinib Hydrochloride CAS 183319-69-9
3-Ethynylaniline CAS 54060-30-9
6,7-Bis(2-Methoxyethoxy)-3H-Quinazolin-4-one CAS 179688-29-0
Please contact: alvin@ruifuchem.com
Ingoa matū | Erlotinib Hydrochloride |
Nga kupu taurite | Erlotinib HCl;Tarceva;CP-358774 Hydrochloride;6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline Hydrochloride;N-(3-Ethynylphe nyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine HCl |
Tau CAS | 183319-69-9 |
Tau CAT | RF-PI2242 |
Tūnga Taonga | I roto i te Stock, Production Tauine Up ki Taranata |
Tātai rāpoi | C22H24ClN3O4 |
Taumaha rāpoi | 429.90 |
Waitohu | Ruifu Chemical |
Tūemi | Whakatakotoranga |
Te ahua | Ma ki te Paura Tioata-White |
Tautuhinga | A: IR: Whakautu ki te Tohu Tohutoro B: HPLC: Whakautu ki te Tohutoro RT |
Wairewa | He iti rawa te whakarewa i roto i te wai, he iti te wairewa i te methanol me te koretake i roto i te Acetonitrile, Acetone, Ethyl Acetate me te Hexane |
Iwi Whakarewa | 223.0~229.0 ℃ |
Ngaronga i te whakamaroke | <0.50% |
Te toenga i runga i te mura | <0.20% |
Nga Korewa Taamaha | <20ppm |
Te poke kotahi | <0.50% |
Nga poke katoa | <1.00% |
Wairewa toenga | |
Pyridine | <4000ppm |
Chloroform | <4000ppm |
DMF | <3000ppm |
Te Maama / Tikanga Tatauria | >99.0% |
Tikanga Whakamatau / Tatau | 98.5%~101.0% (Kua Tatauhia i runga i te Waiwai) |
Paerewa Whakamatau | Paerewa hinonga |
Whakamahinga | API |
Mōkī: Pounamu, Peeke konumohe konumohe, 25kg / Kaata Drum, kia rite ranei ki te hiahia a te kaihoko
Tikanga Rokiroki:Whakaorangia i roto i nga ipu kua hiri ki te waahi makariri me te maroke;Tiaki i te marama me te makuku
Ko te Erlotinib Hydrochloride (CAS: 183319-69-9) he ngota ngota iti o te epidermal growth factor receptor tyrosine kinase reversible inhibitor, te nuinga whakamahia i roto i te maimoatanga o te rohe matatau metastatic ranei mate pukupuku pūtau kore iti pūkahukahu me te raina tuarua ranei e toru raina maimoatanga o mate pukupuku pancreatic.I whakamanahia a Erlotinib Hydrochloride i te marama o Noema, 2004, mo te maimoatanga o te mate pukupuku o te huhu kore-iti-iti ranei.No te karaehe rite ki a Gefitinib, tetahi atu quinazoline i whakaaetia mo te maimoatanga o te mate pukupuku o te huhu o mua, engari he pai ake nga taonga pharmacokinetic.I ahu mai te ngota ngota e Pfizer me te whanaketanga i timatahia i runga i te mahi tahi me OSI, i mau i nga mana katoa ki te tarukino i te hanumi a Pfizer me Warner Lambert.I muri mai, ka uru a Genentech/Roche ki te whakaaetanga raihana me OSI ki te whakawhanake me te hokohoko i te tarukino ki te US me te Ao.Ko te kaiwhakawhiwhi tauwehe epidermal growth factor (EGFR)-tyrosine kinase inhibitor.Atineoplastic.Ko Erlotinib Hydrochloride he aukati HER1 / EGFR me te IC50 o te 2 nM.Kei te waatea a Erlotinib HCl hei 25-, 100-, me te 150-mg papa mo te whakahaere waha.